Filter posts

IPAB: Bad Medicine for Patient Care

The Independent Payment Advisory Board is bad medicine for patient care, deficit reduction and containing …

The Pivotal Role the Public Market Plays in Financing R&D

Growing innovators are the heart of our industry. Biotech small businesses face a dual struggle …

Nationwide Track and Trace System is Urgently Needed

Today’s pharmaceutical distribution supply chain is governed largely by a patchwork of state laws and …

Sen. Grassley Raises Concerns over 340B Program

In a memo written this week, Sen. Chuck Grassley (R-IA) responded to a recent Kaiser …

Congress Acts to Protect Public Health this Flu Season

The next flu season may be months away, but Congress already acted to ensure our …

Inside Health Policy: Clearing Up Confusion About Bills Updating Vaccine Tax Code

Inside Health Policy’s Alaina Busch wrote a story today on confusion that has been spreading …

Thoughts on the President's State of the Union

I had several thoughts watching President Obama’s State of the Union Address tonight. First, we …

The Presidential Inaugural: Looking Back at 30 Years of Biotech Policy Milestones

As President Barack Obama prepares for his second inauguration, we decided that it would be …

Measuring the Impact of Innovation

By Joe Allen, President, Allen and Associates It’s always an indication of interest and importance …

Let's Get PDUFA V Approved, Fast

By Marc Boutin, JD, Executive Vice President and Chief Operating Officer, National Health Council At …